Evidence map›Paper›PMID 32650036›Full record

ArticleDiabetes research and clinical practice2020

Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.

Athanasios Christoforidis, Evgenia Kavoura, Aggeliki Nemtsa, Konstantina Pappa, Meropi Dimitriadou

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 6 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 6 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pediatric endocrinopathies related to COVID-19: an update.World journal of pediatrics : WJP · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Endocrine manifestations of COVID-19 in children: A scoping review.Best practice & research. Clinical endocrinology & metabolism · 2023
    Article
  13. Article
  14. Review
  15. Observational
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Athanasios Christoforidis1st Paediatric Department, Aristotle University, Ippokration General Hospital, 49(th) Konstantinoupoleos str, P.C.: 54642, Thessaloniki, Greece. Electronic address: christoforidis@auth.gr.
Evgenia KavouraMedtronic Hellas S.A., 9th klm Thessaloniki-Moudianion, P.C.: 55535, Pilea, Greece.
Aggeliki Nemtsa1st Paediatric Department, Aristotle University, Ippokration General Hospital, 49(th) Konstantinoupoleos str, P.C.: 54642, Thessaloniki, Greece.
Konstantina Pappa1st Paediatric Department, Aristotle University, Ippokration General Hospital, 49(th) Konstantinoupoleos str, P.C.: 54642, Thessaloniki, Greece.
Meropi Dimitriadou1st Paediatric Department, Aristotle University, Ippokration General Hospital, 49(th) Konstantinoupoleos str, P.C.: 54642, Thessaloniki, Greece.
Ippokrateio General Hospital of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsOn the 10th of March, Greece imposed the closure of schools and universities and a full lockdown a few days later in order to counter the spread of the coronavirus outbreak. Our aim was to monitor the effect of the coronavirus lockdown in diabetes management in children with Type 1 Diabetes Mellitus (T1DM) wearing insulin pump equipped with continuous glucose monitoring system.

methodsIn 34 children with T1DM on Medtronic 640G insulin pump equipped with the Enlite Sensor uploaded CareLink data were categorized in 2 three-week periods before and after the 10th of March.

resultsMean time in range (TIR) did not significantly differ between the two periods. However, a significantly higher Coefficient of Variation (CV) indicating an increased glucose variability in the pre-lockdown period was observed (39.52% versus 37.40%, p = 0.011). Blood glucose readings were significantly fewer during the lockdown period (7.91 versus 7.41, p = 0.001). No significant difference was recorded regarding the total daily dose of insulin and the reported carbohydrates consumed. However, the meal schedule has changed dramatically as the percentage of breakfast consumed before 10.00 a.m. has fallen from 80.67% to 41.46% (p < 0.001) during the lockdown. Correspondingly, the percentage of dinner consumption before 10.00 p.m. significantly fell during the lockdown period (60.22% versus 53.78%, p = 0.019).

conclusionsGlycemic control during the coronavirus lockdown can be adequately achieved and be comparable to the pre-lockdown period in children with type 1 diabetes mellitus wearing insulin pump equipped with sensor.

Indexed as

AdolescentBetacoronavirusBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolCoronavirus InfectionsCOVID-19Diabetes Mellitus, Type 1FemaleGreeceHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsMaleBlood GlucoseHypoglycemic AgentsInsulinChildrenCoronavirusLockdownQuarantineType 1 diabetes

Identifiers

PMID32650036
PMCPMC7340587
OpenAlexW3039272068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.